Determination That VIBRAMYCIN (Doxycycline) for Oral Suspension, Equivalent 25 Milligrams Base/5 Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, Food and Drug Administration. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This rule withdraws a previously issued regulatory action affecting applicable regulations.

Document Details

Document Number	2025-06053
Type	Notice
Published	Apr 9, 2025
Effective Date	-
RIN	-
Docket ID	Docket No. FDA-2025-P-0100
Text Fetched	No

Agencies & CFR References

Agency Hierarchy:

Health and Human Services Department→Food and Drug Administration

CFR References:

None

Linked CFR Parts

Part	Name	Agency
No linked CFR parts

Paired Documents

Type	Proposed	Final	Method	Conf
No paired documents

External Links

View on FederalRegister.gov Search Regulations.gov

Full Text

Text Not Yet Fetched

The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.

Doc #	Type	Title	Published
2025-16853	Notice	Agency Information Collection Activities...	Sep 3, 2025
2025-10886	Notice	Agency Information Collection Activities...	Jun 16, 2025